CD4 and HIV-1 infection: Of 607 individuals initiating cART within one year of seroconversion and with CD4 counts >350 cells/μl, 338 (55.7%) were from the PRIMO cohort in France, reflecting the policy in this country during the 1996–2004 period to systematically treat individuals presenting during primary HIV-1 infection.